NM
NEA Management Company, LLC
TIMONIUM MD · SEC CIK 0001512848
$1.59B2026Q2 reported value
26Positions
89.8%Top 10 weight · largest 15.5%
1 / 1New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
KPTI New+$5.64M
2026Q2 top sells estimated at quarter-end value
Arcellx, Inc. Sold out-$349.66M
CELC Reduced-$60.16M
CVRx, Inc. Reduced-$368,245
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | $246.59M | 15.53% | 13,222,228 | 0 | 0.0% | — | Unchanged |
| MBX | MBX Biosciences, Inc. | $199.52M | 12.56% | 3,614,486 | 0 | 0.0% | — | Unchanged |
| GLUE | Monte Rosa Therapeutics, Inc. | $186.15M | 11.72% | 7,692,298 | 0 | 0.0% | — | Unchanged |
| CELC | Celcuity Inc. | $178.96M | 11.27% | 1,710,561 | -575,000 | -25.2% | -$60.16M | Reduced |
| SGP | Spyglass Pharma, Inc. | $164.55M | 10.36% | 7,392,301 | 0 | 0.0% | — | Unchanged |
| SVRA | Savara, Inc. | $150.74M | 9.49% | 24,471,264 | 0 | 0.0% | — | Unchanged |
| ZBIO | Zenas BioPharma, Inc. | $102.11M | 6.43% | 4,023,219 | 0 | 0.0% | — | Unchanged |
| COUR | Coursera, Inc. | $72.57M | 4.57% | 12,867,769 | 0 | 0.0% | — | Unchanged |
| AUPH | Aurinia Pharmaceuticals, Inc. | $67.37M | 4.24% | 3,969,834 | 0 | 0.0% | — | Unchanged |
| CRSP | CRISPR Therapeutics AG | $57.73M | 3.64% | 1,058,570 | 0 | 0.0% | — | Unchanged |
| ORIC | ORIC Pharmaceuticals, Inc. | $44.60M | 2.81% | 4,118,621 | 0 | 0.0% | — | Unchanged |
| PHAT | Phathom Pharmaceuticals, Inc. | $21.27M | 1.34% | 1,960,169 | 0 | 0.0% | — | Unchanged |
| KRRO | Korro Bio, Inc. | $17.11M | 1.08% | 1,297,893 | 0 | 0.0% | — | Unchanged |
| — | X4 Pharmaceuticals, Inc. | $15.10M | 0.95% | 3,233,743 | 0 | 0.0% | — | Unchanged |
| — | Champions Oncology, Inc. | $10.56M | 0.66% | 1,713,720 | 0 | 0.0% | — | Unchanged |
| NKTX | Nkarta, Inc. | $10.10M | 0.64% | 3,568,781 | 0 | 0.0% | — | Unchanged |
| — | CVRx, Inc. | $10.05M | 0.63% | 1,954,440 | -71,643 | -3.5% | -$368,245 | Reduced |
| — | Black Diamond Therapeutics, Inc. | $8.23M | 0.52% | 4,448,757 | 0 | 0.0% | — | Unchanged |
| KPTI | Karyopharm Therapeutics Inc. | $5.64M | 0.35% | 576,780 | 576,780 | — | $5.64M | New |
| IVA | Inventiva SA | $5.53M | 0.35% | 1,462,586 | 0 | 0.0% | — | Unchanged |
| — | LeonaBio, Inc. | $4.27M | 0.27% | 464,398 | 0 | 0.0% | — | Unchanged |
| — | Senti Biosciences, Inc. | $4.15M | 0.26% | 3,775,615 | 0 | 0.0% | — | Reappeared |
| — | Marker Therapeutics, Inc. | $2.39M | 0.15% | 1,625,678 | 0 | 0.0% | — | Unchanged |
| OKUR | OnKure Therapeutics, Inc. | $2.18M | 0.14% | 478,548 | 0 | 0.0% | — | Unchanged |
| — | ImageneBio, Inc. | $295,030 | 0.02% | 50,005 | 0 | 0.0% | — | Unchanged |
| — | Gossamer Bio, Inc. | $164,600 | 0.01% | 1,000,000 | 0 | 0.0% | — | Unchanged |
| — | Arcellx, Inc. | $0 | 0.00% | 0 | -3,045,262 | -100.0% | -$349.66M | Sold out |